Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New statement proposes ways to stop deadly drug errors among heart, stroke patients

12.11.2002


Better educating physicians, using computers to order drugs and improving the system for policing inappropriate medication use can help reduce potentially deadly errors among cardiovascular patients, according to a new American Heart Association scientific statement published in today’s Circulation: Journal of the American Heart Association.



Several reports have blamed medical errors for thousands of adverse events and deaths among patients in recent years. One study estimates that medical errors occur in 3.7 percent to 16.6 percent of hospitalized patients, contributing to at least 44,000 deaths in the United States each year. Data on deaths due to medical errors involving heart disease and stroke patients is more limited, but a small study of 182 deaths from cerebrovascular disease, pneumonia or heart attack suggests that 14 percent to 27 percent of the deaths may have been avoidable.

Additionally, a study of 203 cases of cardiac arrest concluded that about 7 percent of the arrests may have been prevented, says Jane E. Freedman, M.D., a member of the American Heart Association’s Committee on Acute Cardiac Care and lead author of the statement. Medication error was the most common cause of potentially preventable arrest, occurring in 44 percent of cases. Mistakes can be made while prescribing, transcribing, dispensing, administering or monitoring medication. Sometimes the incorrect drug is prescribed or dispensed, while other times drug dosages are so high that they are toxic. Another error is creating a dangerous combination with other drugs.


Noting the small size of the studies, Freedman says, "There really isn’t any good general data regarding death caused by medication error among cardiovascular patients. But whatever the exact figures are, it is clear from what we know that patient safety can be improved.

"We need to figure out how to best police errors and develop a system to evaluate how big a problem medical errors are in cardiac care," says Freedman, an associate professor of medicine, pharmacology and experimental therapeutics at Boston University School of Medicine.

According to The National Coordinating Council for Medication Error and Prevention, a medication error is ". . .any preventable event that may cause or lead to inappropriate medication use or patient harm, while the medication is in the control of the health care professional, patient, or consumer."

Recommendations for reducing deaths due to medication error highlighted in the statement include: · Improve reporting of medication errors.

Staff self-reporting, currently the most common method of reporting errors, catches fewer than half of adverse events, Freedman says. "Many doctors are afraid of litigation, a dilemma that must be addressed as part of the overall solution."

· Develop a system to control errors.

"Computers are helping," Freedman says. "Some hospitals, for example, have computerized systems that say, ’Don’t use these two drugs together.’"

Other suggestions: Use streamlined protocols that consider all recent drugs the patient has been prescribed. Also, use standardized order forms that include prompts to record a patient’s weight if needed to calculate the correct dosage.

· Improve education.

"We have to better train doctors to be aware of drugs with similar names," she says. For example, the calcium channel blocker Cardene can be confused with the calcium channel blockers Cardizem or Cardizem SR, or the narcotic codeine.

Physicians should refer to fibrinolytic or clot-dissolving drugs by their full generic or brand names and avoid abbreviations even in their handwritten orders.

Doctors also need to be educated about using newer medications. For example, if a new, low-molecular weight heparin is substituted for traditional unfractionated heparin, the dosage of other medications may change too, she notes.

· Address errors of omission.

"While not always considered a safety error, this is a big problem in cardiac care," Freedman says. "Studies show that not everyone leaving the hospital who should be getting potentially lifesaving medications such as beta blockers or aspirin are getting them."

Finally, Freedman says, adverse events occur due to poor handwriting. "If you scribble a prescription rather than type it, the chances of medication error are so much greater," she says. "This error should never happen."


Coauthors are Richard C. Becker, M.D.; Jesse E. Adams, M.D.; Steven Borzak, M.D.; Robert L. Jesse, M.D.; L. Kristin Newby, M.D.; Patrick O’Gara, M.D.; John C. Pezzullo, M.D.; Richard Kerber, M.D.; Bernice Coleman, M.D.; Joseph Broderick, M.D.; Sally Yasuda, M.D.; and Christopher Cannon, M.D.

Carole Bullock | EurekAlert!
Further information:
http://www.americanheart.org/

More articles from Health and Medicine:

nachricht Penn vet research identifies new target for taming Ebola
12.01.2017 | University of Pennsylvania

nachricht The strange double life of Dab2
10.01.2017 | University of Miami Miller School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

Im Focus: Bacterial Pac Man molecule snaps at sugar

Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.

The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Water - as the underlying driver of the Earth’s carbon cycle

17.01.2017 | Earth Sciences

Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

17.01.2017 | Materials Sciences

Smart homes will “LISTEN” to your voice

17.01.2017 | Architecture and Construction

VideoLinks
B2B-VideoLinks
More VideoLinks >>>